Status:
COMPLETED
The Role of B Cells in Kidney Allograft Dysfunction
Lead Sponsor:
Loma Linda University
Conditions:
Kidney; Complications, Allograft
Transplantation Infection
Eligibility:
All Genders
2-85 years
Brief Summary
The purpose of this study is to understand the role of specific B cells in activating or repressing an anti-allograft immune response after kidney transplantation. In this study, blood will be collect...
Detailed Description
The purpose of this study is to understand the role of specific B cells in activating or repressing an anti-allograft immune responses after kidney transplantation. This study aims to address two majo...
Eligibility Criteria
Inclusion
- Ability to understand and willingness to sign the written informed consent form (ICF). For pediatric patients, a parent or legal guardian must sign ICF
- Either a Kidney or Liver transplant patient: 1) on the waitlist or 2) transplanted
- Healthy volunteer samples collected to use as the control group for statistical validity
Exclusion
- Inability to make all of the required long-term post-transplant visits.
- Females who are pregnant or nursing a child
- Liver patients with hepatitis C virus
Key Trial Info
Start Date :
August 28 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 24 2023
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT02294032
Start Date
August 28 2014
End Date
April 24 2023
Last Update
May 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Medical Center, Transplantation Institute
Loma Linda, California, United States, 92354